Role of natural autoantibodies and natural IgM anti-leucocyte autoantibodies in health and disease

Frontiers in Immunology

Volumn 7, Issue JUN, 2016, Pages

  Lobo, Peter Isaac ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Allograft rejection; Autoimmune insulitis; Natural autoantibodies; Natural IgG autoantibodies; Natural IgM anti leukocyte antibodies; Natural IgM autoantibodies; Regulation of co stimulatory receptors; Regulatory dendritic cells; Renal IRI; TH 17

Indexed keywords

AUTOANTIBODY; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GAMMA INTERFERON RECEPTOR; IMMUNOGLOBULIN M; TOLL LIKE RECEPTOR 4;

ACUTE KIDNEY FAILURE; ADAPTIVE IMMUNITY; ALLOTRANSPLANTATION; APOPTOSIS; AUTOIMMUNITY; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNE RESPONSE; IMMUNIZATION; INFECTION; INFLAMMATION; LUPUS ERYTHEMATOSUS NEPHRITIS; NONHUMAN; PHYLOGENY; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; STREPTOCOCCUS PNEUMONIAE;

EID: 84977553586     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2016.00198     Document Type: Review

References (188)

1. Dooley H, Flajnik MF. Antibody repertoire development in cartilaginous fish. Dev Comp Immunol (2006) 30(1-2):43-56. doi:10.1016/j.dci.2005.06.022
2. Baumgarth N, Herman OC, Jager GC, Brown L, Herzenberg LA, Herzenberg LA. Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system. Proc Natl Acad Sci U S A (1999) 96(5):2250-5. doi:10.1073/pnas.96.5.2250
3. Thurnheer MC, Zuercher AW, Cebra JJ, Bos NA. B1 cells contribute to serum IgM, but not to intestinal IgA, production in gnotobiotic Ig allotype chimeric mice. J Immunol (2003) 170(9):4564-71. doi:10.4049/jimmunol.170.9.4564
4. Lobo PI, Schlegel KH, Bajwa A, Huang L, Kurmaeva E, Wang B, et al. Natural IgM switches the function of lipopolysaccharide-activated murine bone marrow-derived dendritic cells to a regulatory dendritic cell that suppresses innate inflammation. J Immunol (2015) 195(11):5215-26. doi:10.4049/jimmunol.1500052
5. Robey IF, Schluter SF, Akporiaye E, Yocum DE, Marchalonis JJ. Human monoclonal natural autoantibodies against the T-cell receptor inhibit interleukin-2 production in murine T cells. Immunology (2002) 105(4):419-29. doi:10.1046/j.1365-2567.2002.01389.x
6. Zhang M, Alicot EM, Carroll MC. Human natural IgM can induce ischemia/reperfusion injury in a murine intestinal model. Mol Immunol (2008) 45(15):4036-9. doi:10.1016/j.molimm.2008.06.013
7. Steele E, Cunningham A. High proportion of Ig-producing cells making autoantibody in normal mice. Nature (1978) 274:483-4. doi:10.1038/274483a0
8. Dighiero G, Guilbert B, Fermand J, Lymberi P, Danon F, Avrameas S. Thirty-six human monoclonal immunoglobulins with antibody activity. Blood (1983) 62(2):264-70.
9. Hardy RR, Hayakawa K. Development and physiology of Ly-1 B and its human homolog, Leu-1 B. Immunol Rev (1986) 93(1):53-80. doi:10.1111/j.1600-065X.1986.tb01502.x
10. Kantor AB, Herzenberg LA. Origin of murine B cell lineages. Annu Rev Immunol (1993) 11(1):501-38. doi:10.1146/annurev.iy.11.040193.002441
11. Nakamura M, Burastero SE, Ueki Y, Larrick JW, Notkins AL, Casali P. Probing the normal and autoimmune B cell repertoire with Epstein-Barr virus. Frequency of B cells producing monoreactive high affinity autoantibodies in patients with Hashimoto's disease and systemic lupus erythematosus. J Immunol (1988) 141(12):4165-72.
12. Mouthon L, Lacroix-Desmazes S, Nobrega A, Barreau C, Coutinho A, Kazatchkine M. The self-reactive antibody repertoire of normal human serum IgM is acquired in early childhood and remains conserved throughout life. Scand J Immunol (1996) 44(3):243-51. doi:10.1046/j.1365-3083.1996.d01-306.x
13. Clarke SH, Arnold LW. B-1 cell development: evidence for an uncommitted immunoglobulin (Ig)M+ B cell precursor in B-1 cell differentiation. J Exp Med (1998) 187(8):1325-34. doi:10.1084/jem.187.8.1325
14. Casali P, Burastero SE, Nakamura M, Inghirami G, Notkins AL. Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset. Science (1987) 236(4797):77-81. doi:10.1126/science.3105056
15. Hardy RR, Hayakawa K, Shimizu M, Yamasaki K, Kishimoto T. Rheumatoid factor secretion from human Leu-1+ B cells. Science (1987) 236(4797):81-3. doi:10.1126/science.3105057
16. Kasaian MT, Casali P. Autoimmunity-prone Bl (CD5 B) cells, natural antibodies and self recognition. Autoimmunity (1993) 15(4):315-29. doi:10.3109/08916939309115755
17. Rieben R, Roos A, Muizert Y, Tinguely C, Gerritsen AF, Daha MR. Immunoglobulin M-enriched human intravenous immunoglobulin prevents complement activation in vitro and in vivo in a rat model of acute inflammation. Blood (1999) 93(3):942-51.
18. Sidman CL, Shultz LD, Hardy RR, Hayakawa K, Herzenberg LA. Production of immunoglobulin isotypes by ly-1+ B cells in viable motheaten and normal mice. Science (1986) 232(4756):1423-5. doi:10.1126/science.3487115
19. Solvason N, Lehuen A, Kearney JF. An embryonic source of Ly1 but not conventional B cells. Int Immunol (1991) 3(6):543-50. doi:10.1093/intimm/3.6.543
20. Murakami M, Tsubata T, Shinkura R, Nisitani S, Okamoto M, Yoshioka H, et al. Oral administration of lipopolysaccharides activates B-1 cells in the peritoneal cavity and lamina propria of the gut and induces autoimmune symptoms in an autoantibody transgenic mouse. J Exp Med (1994) 180(1):111-21. doi:10.1084/jem.180.1.111
21. Nisitani S, Tsubata T, Murakami M, Honjo T. Administration of interleukin-5 or-10 activates peritoneal B-1 cells and induces autoimmune hemolytic anemia in anti-erythrocyte autoantibody-transgenic mice. Eur J Immunol (1995) 25(11):3047-52. doi:10.1002/eji.1830251110
22. Yang Y, Tung JW, Ghosn EEB, Herzenberg LA, Herzenberg LA. Division and differentiation of natural antibody-producing cells in mouse spleen. Proc Natl Acad Sci U S A (2007) 104(11):4542-6. doi:10.1073/pnas.0700001104
23. Ha S, Tsuji M, Suzuki K, Meek B, Yasuda N, Kaisho T, et al. Regulation of B1 cell migration by signals through Toll-like receptors. J Exp Med (2006) 203(11):2541-50. doi:10.1084/jem.20061041
24. Hayakawa K, Asano M, Shinton SA, Gui M, Allman D, Stewart CL, et al. Positive selection of natural autoreactive B cells. Science (1999) 285(5424):113-6. doi:10.1126/science.285.5424.113
25. Martin F, Kearney JF. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Immunity (2000) 12(1):39-49. doi:10.1016/S1074-7613(00)80157-0
26. Cancro MP, Kearney JF. B cell positive selection: road map to the primary repertoire? J Immunol (2004) 173(1):15-9. doi:10.4049/jimmunol.173.1.15
27. Tian Q, Beardall M, Xu Y, Li J, Parker DC, Casanova N, et al. B cells expressing a natural polyreactive autoantibody have a distinct phenotype and are overrepresented in immunoglobulin heavy chain transgenic mice. J Immunol (2006) 177(4):2412-22. doi:10.4049/jimmunol.177.4.2412
28. Love SD, Lee W, Nakamura YC, Platt JL, Bollinger RR, Parker W. Natural anti-carbohydrate IgM in mice: dependence on age and strain. J Immunol Methods (2000) 246(1):61-8. doi:10.1016/S0022-1759(00)00296-9
29. Griffin DO, Holodick NE, Rothstein TL. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70-. J Exp Med (2011) 208(1):67-80. doi:10.1084/jem.20101499
30. Simell B, Lahdenkari M, Reunanen A, Kayhty H, Vakevainen M. Effects of ageing and gender on naturally acquired antibodies to pneumococcal capsular polysaccharides and virulence-associated proteins. Clin Vaccine Immunol (2008) 15(9):1391-7. doi:10.1128/CVI.00110-08
31. Adib M, Ragimbeau J, Avrameas S, Ternynck T. IgG autoantibody activity in normal mouse serum is controlled by IgM. J Immunol (1990) 145(11):3807-13.
32. Nicoletti C, Yang X, Cerny J. Repertoire diversity of antibody response to bacterial antigens in aged mice. III. Phosphorylcholine antibody from young and aged mice differ in structure and protective activity against infection with Streptococcus pneumoniae. J Immunol (1993) 150(2):543-9.
33. Lacroix-Desmazes S, Mouthon L, Kaveri SV, Kazatchkine MD, Weksler ME. Stability of natural self-reactive antibody repertoires during aging. J Clin Immunol (1999) 19(1):26-34. doi:10.1023/A:1020510401233
34. Nagele EP, Han M, Acharya NK, DeMarshall C, Kosciuk MC, Nagele RG. Natural IgG autoantibodies are abundant and ubiquitous in human sera, and their number is influenced by age, gender, and disease. PLoS One (2013) 8(4):e60726. doi:10.1371/journal.pone.0060726
35. Lacroix-Desmazes S, Mouthon L, Coutinho A, Kazatchkine MD. Analysis of the natural human IgG antibody repertoire: life-long stability of reactivities towards self antigens contrasts with age-dependent diversification of reactivities against bacterial antigens. Eur J Immunol (1995) 25(9):2598-604. doi:10.1002/eji.1830250929
36. Bachi AL, Suguri VM, Ramos LR, Mariano M, Vaisberg M, Lopes JD. Increased production of autoantibodies and specific antibodies in response to influenza virus vaccination in physically active older individuals. Results Immunol (2013) 3:10-6. doi:10.1016/j.rinim.2013.01.001
37. Covens K, Verbinnen B, Geukens N, Meyts I, Schuit F, Van Lommel L, et al. Characterization of proposed human B-1 cells reveals pre-plasmablast phenotype. Blood (2013) 121(26):5176-83. doi:10.1182/blood-2012-12-471953
38. Tangye SG. To B1 or not to B1: that really is still the question! Blood (2013) 121(26):5109-10. doi:10.1182/blood-2013-05-500074
39. Lobo PI, Schlegel KH, Spencer CE, Okusa MD, Chisholm C, McHedlishvili N, et al. Naturally occurring IgM anti-leukocyte autoantibodies (IgM-ALA) inhibit T cell activation and chemotaxis. J Immunol (2008) 180(3):1780-91. doi:10.4049/jimmunol.180.3.1769
40. Chen ZJ, Wheeler CJ, Shi W, Wu AJ, Yarboro CH, Gallagher M, et al. Polyreactive antigen-binding B cells are the predominant cell type in the newborn B cell repertoire. Eur J Immunol (1998) 28(3):989-94. doi:10.1002/(SICI)1521-4141(199803)28:03<989::AID-IMMU989>3.0.CO;2-1
41. Chou MY, Fogelstrand L, Hartvigsen K, Hansen LF, Woelkers D, Shaw PX, et al. Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. J Clin Invest (2009) 119(5):1335-49. doi:10.1172/JCI36800
42. Kroese FG, Butcher EC, Stall AM, Herzenberg LA. A major peritoneal reservoir of precursors for intestinal IgA plasma cells. Immunol Invest (1989) 18(1-4):47-58. doi:10.3109/08820138909112226
43. Murakami M, Honjo T. Involvement of B-1 cells in mucosal immunity and autoimmunity. Immunol Today (1995) 16(11):534-9. doi:10.1016/0167-5699(95)80047-6
44. Fagarasan S, Kinoshita K, Muramatsu M, Ikuta K, Honjo T. In situ class switching and differentiation to IgA-producing cells in the gut lamina propria. Nature (2001) 413(6856):639-43. doi:10.1038/35098100
45. Bowman EP, Kuklin NA, Youngman KR, Lazarus NH, Kunkel EJ, Pan J, et al. The intestinal chemokine thymus-expressed chemokine (CCL25) attracts IgA antibody-secreting cells. J Exp Med (2002) 195(2):269-75. doi:10.1084/jem.20010670
46. Golby SJ, Spencer J. Where do IgA plasma cells in the gut come from? Gut (2002) 51(2):150-1. doi:10.1136/gut.51.2.150
47. Herzenberg LA. B-1 cells: the lineage question revisited. Immunol Rev (2000) 175(1):9-22. doi:10.1111/j.1600-065X.2000.imr017520.x
48. Berland R, Wortis HH. Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol (2002) 20(1):253-300. doi:10.1146/annurev.immunol.20.100301.064833
49. Rothstein TL. Cutting edge commentary: two B-1 or not to be one. J Immunol (2002) 168(9):4257-61. doi:10.4049/jimmunol.168.9.4257
50. Avrameas S. Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton'. Immunol Today (1991) 12(5):154-9. doi:10.1016/S0167-5699(05)80045-3
51. Kretschmer K, Jungebloud A, Stopkowicz J, Kleinke T, Hoffmann R, Weiss S. The selection of marginal zone B cells differs from that of B-1a cells. J Immunol (2003) 171(12):6495-501. doi:10.4049/jimmunol.171.12.6495
52. Martin F, Kearney JF. Marginal-zone B cells. Nat Rev Immunol (2002) 2(5):323-35. doi:10.1038/nri799
53. Zhou Z, Tzioufas AG, Notkins AL. Properties and function of polyreactive antibodies and polyreactive antigen-binding B cells. J Autoimmun (2007) 29(4):219-28. doi:10.1016/j.jaut.2007.07.015
54. Vittecoq O, Brard F, Jovelin F, Le Loet X, Tron F, Gilbert D. IgM anti-myeloperoxidase antibody-secreting lymphocytes are present in the peripheral repertoire of lupus mice but rarely differentiate into IgG-producing cells. Clin Exp Immunol (1999) 118(1):122-30. doi:10.1046/j.1365-2249.1999.00995.x
55. Baumgarth N. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat Rev Immunol (2011) 11(1):34-46. doi:10.1038/nri2901
56. Gronwall C, Vas J, Silverman GJ. Protective roles of natural IgM antibodies. Front Immunol (2012) 3:66. doi:10.3389/fimmu.2012.00066
57. Baxendale HE, Johnson M, Stephens RC, Yuste J, Klein N, Brown JS, et al. Natural human antibodies to pneumococcus have distinctive molecular characteristics and protect against pneumococcal disease. Clin Exp Immunol (2008) 151(1):51-60. doi:10.1111/j.1365-2249.2007.03535.x
58. Rauch PJ, Chudnovskiy A, Robbins CS, Weber GF, Etzrodt M, Hilgendorf I, et al. Innate response activator B cells protect against microbial sepsis. Science (2012) 335(6068):597-601. doi:10.1126/science.1215173
59. Holodick NE, Tumang JR, Rothstein TL. Immunoglobulin secretion by B1 cells: differential intensity and IRF4-dependence of spontaneous IgM secretion by peritoneal and splenic B1 cells. Eur J Immunol (2010) 40(11):3007-16. doi:10.1002/eji.201040545
60. Montecino-Rodriguez E, Leathers H, Dorshkind K. Identification of a B-1 B cell-specified progenitor. Nat Immunol (2006) 7(3):293-301. doi:10.1038/ni1301
61. Matejuk A, Beardall M, Xu Y, Tian Q, Phillips D, Alabyev B, et al. Exclusion of natural autoantibody-producing B cells from IgG memory B cell compartment during T cell-dependent immune responses. J Immunol (2009) 182(12):7634-43. doi:10.4049/jimmunol.0801562
62. Ishida D, Su L, Tamura A, Katayama Y, Kawai Y, Wang SF, et al. Rap1 signal controls B cell receptor repertoire and generation of self-reactive B1a cells. Immunity (2006) 24(4):417-27. doi:10.1016/j.immuni.2006.02.007
63. Boes M, Esau C, Fischer MB, Schmidt T, Carroll M, Chen J. Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J Immunol (1998) 160(10):4776-87.
64. Lino AC, Mohr E, Demengeot J. Naturally secreted immunoglobulins limit B1 and MZ B-cell numbers through a microbiota-independent mechanism. Blood (2013) 122(2):209-18. doi:10.1182/blood-2012-08-447136
65. Baker N, Ehrenstein MR. Cutting edge: selection of B lymphocyte subsets is regulated by natural IgM. J Immunol (2002) 169(12):6686-90. doi:10.4049/jimmunol.169.12.6686
66. Choi SC, Wang H, Tian L, Murakami Y, Shin DM, Borrego F, et al. Mouse IgM Fc receptor, FCMR, promotes B cell development and modulates antigen-driven immune responses. J Immunol (2013) 190(3):987-96. doi:10.4049/jimmunol.1202227
67. Amezcua Vesely MC, Schwartz M, Bermejo DA, Montes CL, Cautivo KM, Kalergis AM, et al. FcγRIIb and BAFF differentially regulate peritoneal B1 cell survival. J Immunol (2012) 188(10):4792-800. doi:10.4049/jimmunol.1102070
68. Berneman A, Ternynck T, Avrameas S. Natural mouse IgG reacts with self antigens including molecules involved in the immune response. Eur J Immunol (1992) 22(3):625-33. doi:10.1002/eji.1830220303
69. Vargas ME, Watanabe J, Singh SJ, Robinson WH, Barres BA. Endogenous antibodies promote rapid myelin clearance and effective axon regeneration after nerve injury. Proc Natl Acad Sci U S A (2010) 107(26):11993-8. doi:10.1073/pnas.1001948107
70. Hurez V, Kaveri S, Kazatchkine MD. Expression and control of the natural autoreactive IgG repertoire in normal human serum. Eur J Immunol (1993) 23(4):783-9. doi:10.1002/eji.1830230402
71. Pereira P, Forni L, Larsson E, Cooper M, Heusser C, Coutinho A. Autonomous activation of B and T cells in antigen-free mice. Eur J Immunol (1986) 16(6):685-8. doi:10.1002/eji.1830160616
72. Coutinho A, Kazatchkine MD, Avrameas S. Natural autoantibodies. Curr Opin Immunol (1995) 7(6):812-8. doi:10.1016/0952-7915(95)80053-0
73. Bos NA, Kimura H, Meeuwsen CG, Visser HD, Hazenberg MP, Wostmann BS, et al. Serum immunoglobulin levels and naturally occurring antibodies against carbohydrate antigens in germ-free BALB/c mice fed chemically defined ultrafiltered diet. Eur J Immunol (1989) 19(12):2335-9. doi:10.1002/eji.1830191223
74. Hamanova M, Chmelikova M, Nentwich I, Thon V, Lokaj J. Anti-gal IgM, IgA and IgG natural antibodies in childhood. Immunol Lett (2015) 164(1):40-3. doi:10.1016/j.imlet.2015.02.001
75. Cohen IR, Young DB. Autoimmunity, microbial immunity and the immunological homunculus. Immunol Today (1991) 12(4):105-10. doi:10.1016/0167-5699(91)90093-9
76. Watts RA, Isenberg DA. Autoantibodies and antibacterial antibodies: from both sides now. Ann Rheum Dis (1990) 49(12):961-5. doi:10.1136/ard.49.12.961
77. Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC. Predominant autoantibody production by early human B cell precursors. Science (2003) 301(5638):1374-7. doi:10.1126/science.1086907
78. Xu PC, Cui Z, Chen M, Hellmark T, Zhao MH. Comparison of characteristics of natural autoantibodies against myeloperoxidase and anti-myeloperoxidase autoantibodies from patients with microscopic polyangiitis. Rheumatology (Oxford) (2011) 50(7):1236-43. doi:10.1093/rheumatology/ker085
79. Reap EA, Sobel ES, Jennette JC, Cohen PL, Eisenberg RA. Conventional B cells, not B1 cells, are the source of autoantibodies in chronic graft-versus-host disease. J Immunol (1993) 151(12):7316-23.
80. Wofsy D, Ledbetter JA, Hendler PL, Seaman WE. Treatment of murine lupus with monoclonal anti-T cell antibody. J Immunol (1985) 134(2):852-7.
81. Jevnikar AM, Grusby MJ, Glimcher LH. Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice. J Exp Med (1994) 179(4):1137-43. doi:10.1084/jem.179.4.1137
82. Steinberg AD, Roths JB, Murphy ED, Steinberg RT, Raveche ES. Effects of thymectomy or androgen administration upon the autoimmune disease of MRL/Mp-lpr/lpr mice. J Immunol (1980) 125(2):871-3.
83. Kaveri S, Dietrich G, Hurez V, Kazatchkine M. Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases. Clin Exp Immunol (1991) 86(2):192-8. doi:10.1111/j.1365-2249.1991.tb05794.x
84. Panda S, Zhang J, Tan NS, Ho B, Ding JL. Natural IgG antibodies provide innate protection against ficolin-opsonized bacteria. EMBO J (2013) 32(22):2905-19. doi:10.1038/emboj.2013.199
85. Abdou NI, Wall H, Lindsley HB, Halsey JF, Suzuki T. Network theory in autoimmunity. in vitro suppression of serum anti-DNA antibody binding to DNA by anti-idiotypic antibody in systemic lupus erythematosus. J Clin Invest (1981) 67(5):1297-304. doi:10.1172/JCI110158
86. Dwyer DS, Bradley RJ, Urquhart CK, Kearney JF. Naturally occurring anti-idiotypic antibodies in myasthenia gravis patients. Nature (1983) 301(5901):611-4.
87. Cui Z, Zhao M, Segelmark M, Hellmark T. Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals. Kidney Int (2010) 78(6):590-7. doi:10.1038/ki.2010.198
88. Ohnishi K, Ebling FM, Mitchell B, Singh RR, Hahn BH, Tsao BP. Comparison of pathogenic and non-pathogenic murine antibodies to DNA: antigen binding and structural characteristics. Int Immunol (1994) 6(6):817-30. doi:10.1093/intimm/6.6.817
89. Ehrenstein MR, Katz DR, Griffiths MH, Papadaki L, Winkler TH, Kalden JR, et al. Human IgG anti-DNA antibodies deposit in kidneys and induce proteinuria in SCID mice. Kidney Int (1995) 48(3):705-11. doi:10.1038/ki.1995.341
90. Tsao BP, Ohnishi K, Cheroutre H, Mitchell B, Teitell M, Mixter P, et al. Failed self-tolerance and autoimmunity in IgG anti-DNA transgenic mice. J Immunol (1992) 149(1):350-8.
91. Radic MZ, Ibrahim SM, Rauch J, Camper SA, Weigert M. Constitutive secretion of transgene-encoded IgG2b autoantibodies leads to symptoms of autoimmune disease. J Immunol (1995) 155(6):3213-22.
92. Murakami M, Tsubata T, Okamoto M, Shimizu A, Kumagai S, Imura H, et al. Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice. Nature (1992) 357:77-80. doi:10.1038/357077a0
93. Takahashi T, Strober S. Natural killer T cells and innate immune B cells from lupus-prone NZB/W mice interact to generate IgM and IgG autoantibodies. Eur J Immunol (2008) 38(1):156-65. doi:10.1002/eji.200737656
94. Murakami M, Yoshioka H, Shirai T, Tsubata T, Honjo T. Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells. Int Immunol (1995) 7(5):877-82. doi:10.1093/intimm/7.5.877
95. Yurasov S, Wardemann H, Hammersen J, Tsuiji M, Meffre E, Pascual V, et al. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J Exp Med (2005) 201(5):703-11. doi:10.1084/jem.20042251
96. Samuels J, Ng Y, Paget D, Meffre E. Impaired early B-cell tolerance in patients with rheumatoid arthritis. Arthritis Res Ther (2005) 7(Suppl 1):78. doi:10.1186/ar1599
97. Lesley R, Xu Y, Kalled SL, Hess DM, Schwab SR, Shu HB, et al. Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity (2004) 20(4):441-53. doi:10.1016/S1074-7613(04)00079-2
98. Groom J, Kalled SL, Cutler AH, Olson C, Woodcock SA, Schneider P, et al. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome. J Clin Invest (2002) 109(1):59-68. doi:10.1172/JCI0214121
99. Guilbert B, Mahana W, Gilbert M, Mazie JC, Avrameas S. Presence of natural autoantibodies in hyperimmunized mice. Immunology (1985) 56(3):401-8.
100. Naparstek Y, Andre-Schwartz J, Manser T, Wysocki LJ, Breitman L, Stollar BD, et al. A single germline VH gene segment of normal A/J mice encodes autoantibodies characteristic of systemic lupus erythematosus. J Exp Med (1986) 164(2):614-26. doi:10.1084/jem.164.2.614
101. Cunningham MW, Hall NK, Krisher KK, Spanier AM. A study of anti-group A streptococcal monoclonal antibodies cross-reactive with myosin. J Immunol (1986) 136(1):293-8.
102. Lewis M, Botto M. Complement deficiencies in humans and animals: links to autoimmunity. Autoimmunity (2006) 39(5):367-78. doi:10.1080/08916930600739233
103. Li F, Smith P, Ravetch JV. Inhibitory Fcγ receptor is required for the maintenance of tolerance through distinct mechanisms. J Immunol (2014) 192(7):3021-8. doi:10.4049/jimmunol.1302934
104. Baerenwaldt A, Lux A, Danzer H, Spriewald BM, Ullrich E, Heidkamp G, et al. Fcγ receptor IIB (FcγRIIB) maintains humoral tolerance in the human immune system in vivo. Proc Natl Acad Sci U S A (2011) 108(46):18772-7. doi:10.1073/pnas.1111810108
105. Tillman DM, Jou NT, Hill RJ, Marion TN. Both IgM and IgG anti-DNA antibodies are the products of clonally selective B cell stimulation in (NZB x NZW)F1 mice. J Exp Med (1992) 176(3):761-79. doi:10.1084/jem.176.3.761
106. Ikematsu H, Kasaian MT, Schettino EW, Casali P. Structural analysis of the VH-D-JH segments of human polyreactive IgG mAb. Evidence for somatic selection. J Immunol (1993) 151(7):3604-16.
107. Werwitzke S, Trick D, Kamino K, Matthias T, Kniesch K, Schlegelberger B, et al. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse. Arthritis Rheum (2005) 52(11):3629-38. doi:10.1002/art.21379
108. Heidenreich F, Jovin T. Synthesis of anti-acetylcholine receptor antibodies by CD5-B cells from peripheral blood of myasthenia gravis patients. J Neurol (1996) 243(1):57-62. doi:10.1007/BF00878532
109. Lubetzki Korn I, Abramsky O. Myasthenia gravis following viral infection. Eur Neurol (1981) 20(6):435-9. doi:10.1159/000115275
110. Hohlfeld R, Kalies I, Kohleisen B, Heininger K, Conti-Tronconi B, Toyka KV. Myasthenia gravis: stimulation of antireceptor autoantibodies by autoreactive T cell lines. Neurology (1986) 36(5):618-21. doi:10.1212/WNL.36.5.618
111. Wang ZY, Okita DK, Howard J Jr, Conti-Fine BM. T-cell recognition of muscle acetylcholine receptor subunits in generalized and ocular myasthenia gravis. Neurology (1998) 50(4):1045-54. doi:10.1212/WNL.50.4.1045
112. Jennette JC, Falk RJ. The rise and fall of horror autotoxicus and forbidden clones. Kidney Int (2010) 78(6):533-5. doi:10.1038/ki.2010.237
113. Jennette JC, Hipp CG. Clq nephropathy: a distinct pathologic entity usually causing nephrotic syndrome. Am J Kidney Dis (1985) 6(2):103-10. doi:10.1016/S0272-6386(85)80150-5
114. Sharman A, Furness P, Feehally J. Distinguishing C1q nephropathy from lupus nephritis. Nephrol Dial Transplant (2004) 19(6):1420-6. doi:10.1093/ndt/gfh139
115. Jacob N, Stohl W. Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and future. Autoimmunity (2010) 43(1):84-97. doi:10.3109/08916930903374600
116. Waters ST, McDuffie M, Bagavant H, Deshmukh US, Gaskin F, Jiang C, et al. Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis. J Exp Med (2004) 199(2):255-64. doi:10.1084/jem.20031519
117. Jiang C, Foley J, Clayton N, Kissling G, Jokinen M, Herbert R, et al. Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice. J Immunol (2007) 178(11):7422-31. doi:10.4049/jimmunol.178.11.7422
118. Ma J, Xu J, Madaio MP, Peng Q, Zhang J, Grewal IS, et al. Autoimmune lpr/lpr mice deficient in CD40 ligand: spontaneous ig class switching with dichotomy of autoantibody responses. J Immunol (1996) 157(1):417-26.
119. Ehrenstein MR, Cook HT, Neuberger MS. Deficiency in serum immunoglobulin (Ig)M predisposes to development of IgG autoantibodies. J Exp Med (2000) 191(7):1253-8. doi:10.1084/jem.191.7.1253
120. Boes M, Schmidt T, Linkemann K, Beaudette BC, Marshak-Rothstein A, Chen J. Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc Natl Acad Sci U S A (2000) 97(3):1184-9. doi:10.1073/pnas.97.3.1184
121. Bolland S, Ravetch JV. Spontaneous autoimmune disease in FcγRIIB-deficient mice results from strain-specific epistasis. Immunity (2000) 13(2):277-85. doi:10.1016/S1074-7613(00)00027-3
122. Côrte-Real J, Rodo J, Almeida P, Garcia J, Coutinho A, Demengeot J, et al. Irf4 is a positional and functional candidate gene for the control of serum IgM levels in the mouse. Genes Immun (2009) 10(1):93-9. doi:10.1038/gene.2008.73
123. Klein-Schneegans A, Kuntz L, Fonteneau P, Loor F. Serum concentrations of IgM, IgG1, IgG2b, IgG3 and IgA in C57BL6 mice and their congenics at the lpr (lymphoproliferation) locus. J Autoimmun (1989) 2(6):869-75. doi:10.1016/0896-8411(89)90013-9
124. Kalpaktsoglou PK, Hong R, Good RA. The five classes of immunoglobulins in normal C3H and BALB/c mice. Immunology (1973) 24(2):303-14.
125. Witte T. IgM antibodies against dsDNA in SLE. Clin Rev Allergy Immunol (2008) 34(3):345-7. doi:10.1007/s12016-007-8046-x
126. Mannoor K, Matejuk A, Xu Y, Beardall M, Chen C. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival. J Immunol (2012) 188(8):3628-38. doi:10.4049/jimmunol.1102859
127. Chen Y, Khanna S, Goodyear CS, Park YB, Raz E, Thiel S, et al. Regulation of dendritic cells and macrophages by an anti-apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis. J Immunol (2009) 183(2):1346-59. doi:10.4049/jimmunol.0900948
128. Lobo PI, Brayman KL, Okusa MD. Natural IgM anti-leucocyte autoantibodies (IgM-ALA) regulate inflammation induced by innate and adaptive immune mechanisms. J Clin Immunol (2014) 34(Suppl 1):S22-9. doi:10.1007/s10875-014-0027-2
129. Hurez V, Kazatchkine MD, Vassilev T, Ramanathan S, Pashov A, Basuyaux B, et al. Pooled normal human polyspecific IgM contains neutralizing anti-idiotypes to IgG autoantibodies of autoimmune patients and protects from experimental autoimmune disease. Blood (1997) 90(10):4004-13.
130. Chen Y, Park YB, Patel E, Silverman GJ. IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells. J Immunol (2009) 182(10):6031-43. doi:10.4049/jimmunol.0804191
131. Lobo PI. Nature of autolymphocytotoxins present in renal hemodialysis patients: their possible role in controlling alloantibody formation. Transplantation (1981) 32(3):233-7. doi:10.1097/00007890-198109000-00010
132. Honjo K, Kubagawa Y, Jones DM, Dizon B, Zhu Z, Ohno H, et al. Altered Ig levels and antibody responses in mice deficient for the Fc receptor for IgM (FcmuR). Proc Natl Acad Sci U S A (2012) 109(39):15882-7. doi:10.1073/pnas.1206567109
133. Hutchings PR, Varey AM, Cooke A. Immunological defects in SJL mice. Immunology (1986) 59(3):445-50.
134. Li QZ, Xie C, Wu T, Mackay M, Aranow C, Putterman C, et al. Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. J Clin Invest (2005) 115(12):3428-39. doi:10.1172/JCI23587
135. Jost SA, Tseng LC, Matthews LA, Vasquez R, Zhang S, Yancey KB, et al. IgG, IgM, and IgA antinuclear antibodies in discoid and systemic lupus erythematosus patients. ScientificWorldJournal (2014) 2014:171028. doi:10.1155/2014/171028
136. Vassilev T, Yamamoto M, Aissaoui A, Bonnin E, Berrih-Aknin S, Kazatchkine MD, et al. Normal human immunoglobulin suppresses experimental myasthenia gravis in SCID mice. Eur J Immunol (1999) 29(8):2436-42. doi:10.1002/(SICI)1521-4141(199908)29:08<2436::AID-IMMU2436>3.0.CO;2-9
137. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med (2003) 349(16):1526-33. doi:10.1056/NEJMoa021933
138. Lobo PI, Bajwa A, Schlegel KH, Vengal J, Lee SJ, Huang L, et al. Natural IgM anti-leukocyte autoantibodies attenuate excess inflammation mediated by innate and adaptive immune mechanisms involving Th-17. J Immunol (2012) 188(4):1675-85. doi:10.4049/jimmunol.1101762
139. Gobet R, Cerny A, Ruedi E, Hengartner H, Zinkernagel RM. The role of antibodies in natural and acquired resistance of mice to vesicular stomatitis virus. Exp Cell Biol (1988) 56(4):175-80.
140. Ochsenbein AF, Fehr T, Lutz C, Suter M, Brombacher F, Hengartner H, et al. Control of early viral and bacterial distribution and disease by natural antibodies. Science (1999) 286(5447):2156-9. doi:10.1126/science.286.5447.2156
141. Ehrenstein MR, Notley CA. The importance of natural IgM: scavenger, protector and regulator. Nat Rev Immunol (2010) 10(11):778-86. doi:10.1038/nri2849
142. Harnett W, Harnett MM. Phosphorylcholine: friend or foe of the immune system? Immunol Today (1999) 20(3):125-9. doi:10.1016/S0167-5699(98)01419-4
143. Tomasz A. Choline in the cell wall of a bacterium: novel type of polymer-linked choline in pneumococcus. Science (1967) 157(3789):694-7. doi:10.1126/science.157.3789.694
144. Lobo PI, Schlegel KH, Yuan W, Townsend GC, White JA. Inhibition of HIV-1 infectivity through an innate mechanism involving naturally occurring IgM anti-leukocyte autoantibodies. J Immunol (2008) 180(3):1769-79. doi:10.4049/jimmunol.180.3.1769
145. Ravichandran KS, Lorenz U. Engulfment of apoptotic cells: signals for a good meal. Nat Rev Immunol (2007) 7(12):964-74. doi:10.1038/nri2214
146. Shaw PX, Horkko S, Chang MK, Curtiss LK, Palinski W, Silverman GJ, et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest (2000) 105(12):1731-40. doi:10.1172/JCI8472
147. Gray M, Miles K, Salter D, Gray D, Savill J. Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc Natl Acad Sci U S A (2007) 104(35):14080-5. doi:10.1073/pnas.0700326104
148. Kearney JF. Immune recognition of OxLDL in atherosclerosis. J Clin Invest (2000) 105(12):1683-5. doi:10.1172/JCI10426
149. Kim SJ, Gershov D, Ma X, Brot N, Elkon KB. I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation. J Exp Med (2002) 196(5):655-65. doi:10.1084/jem.20020542
150. Binder CJ, Horkko S, Dewan A, Chang MK, Kieu EP, Goodyear CS, et al. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med (2003) 9(6):736-43. doi:10.1038/nm876
151. Horkko S, Bird DA, Miller E, Itabe H, Leitinger N, Subbanagounder G, et al. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J Clin Invest (1999) 103(1):117-28. doi:10.1172/JCI4533
152. Bhatia VK, Yun S, Leung V, Grimsditch DC, Benson GM, Botto MB, et al. Complement C1q reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice. Am J Pathol (2007) 170(1):416-26. doi:10.2353/ajpath.2007.060406
153. Fraser DA, Tenner AJ. Innate immune proteins C1q and mannan-binding lectin enhance clearance of atherogenic lipoproteins by human monocytes and macrophages. J Immunol (2010) 185(7):3932-9. doi:10.4049/jimmunol.1002080
154. Lewis MJ, Malik TH, Ehrenstein MR, Boyle JJ, Botto M, Haskard DO. Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation (2009) 120(5):417-26. doi:10.1161/CIRCULATIONAHA.109.868158
155. Walport MJ, Davies KA, Botto M. C1q and systemic lupus erythematosus. Immunobiology (1998) 199(2):265-85. doi:10.1016/S0171-2985(98)80032-6
156. Ogden CA, Kowalewski R, Peng Y, Montenegro V, Elkon KB. IGM is required for efficient complement mediated phagocytosis of apoptotic cells in vivo. Autoimmunity (2005) 38(4):259-64. doi:10.1080/08916930500124452
157. Terasaki PI, Mottironi VD, Barnett EV. Cytotoxins in disease. N Engl J Med (1970) 283(14):724-8. doi:10.1056/NEJM197010012831403
158. Lobo PI, Schlegel KH, Vengal J, Okusa MD, Pei H. Naturally occurring IgM anti-leukocyte autoantibodies inhibit T-cell activation and chemotaxis. J Clin Immunol (2010) 30(1):S31-6. doi:10.1007/s10875-010-9412-7
159. Winfield JB, Winchester RJ, Wernet P, Fu SM, Kunkel HG. Nature of cold-reactive antibodies to lymphocyte surface determinants in systemic lupus erythematosus. Arthritis Rheum (1975) 18(1):1-8. doi:10.1002/art.1780180101
160. Ouchida R, Mori H, Hase K, Takatsu H, Kurosaki T, Tokuhisa T, et al. Critical role of the IgM Fc receptor in IgM homeostasis, B-cell survival, and humoral immune responses. Proc Natl Acad Sci U S A (2012) 109(40):E2699-706. doi:10.1073/pnas.1210706109
161. Lobo PI, Sturgill BC, Bolton WK. Cold-reactive alloantibodies and allograft malfunction occurring immediately posttransplant. Transplantation (1984) 37(1):76-80. doi:10.1097/00007890-198401000-00021
162. Sturgill B, Lobo P, Bolton W. Cold-reacting IgM antibody-induced renal allograft failure. Nephron (1984) 36(2):125-7. doi:10.1159/000183131
163. Zhang M, Austen WG Jr, Chiu I, Alicot EM, Hung R, Ma M, et al. Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proc Natl Acad Sci U S A (2004) 101(11):3886-91. doi:10.1073/pnas.0400347101
164. Betapudi V. Life without double-headed non-muscle myosin II motor proteins. Front Chem (2014) 2:45. doi:10.3389/fchem.2014.00045
165. Austen WG, Zhang M, Chan R, Friend D, Hechtman HB, Carroll MC, et al. Murine hindlimb reperfusion injury can be initiated by a self-reactive monoclonal IgM. Surgery (2004) 136(2):401-6. doi:10.1016/j.surg.2004.05.016
166. Zhang M, Michael LH, Grosjean SA, Kelly RA, Carroll MC, Entman ML. The role of natural IgM in myocardial ischemia-reperfusion injury. J Mol Cell Cardiol (2006) 41(1):62-7. doi:10.1016/j.yjmcc.2006.02.006
167. Arrondel C, Vodovar N, Knebelmann B, Grunfeld JP, Gubler MC, Antignac C, et al. Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes. J Am Soc Nephrol (2002) 13(1):65-74.
168. Renner B, Strassheim D, Amura CR, Kulik L, Ljubanovic D, Glogowska MJ, et al. B cell subsets contribute to renal injury and renal protection after ischemia/reperfusion. J Immunol (2010) 185(7):4393-400. doi:10.4049/jimmunol.0903239
169. Li L, Huang L, Sung SS, Lobo PI, Brown MG, Gregg RK, et al. NKT cell activation mediates neutrophil IFN-gamma production and renal ischemia-reperfusion injury. J Immunol (2007) 178(9):5899-911. doi:10.4049/jimmunol.178.9.5899
170. Burne-Taney MJ, Yokota-Ikeda N, Rabb H. Effects of combined T-and B-cell deficiency on murine ischemia reperfusion injury. Am J Transplant (2005) 5(6):1186-93. doi:10.1111/j.1600-6143.2005.00815.x
171. Gigliotti JC, Huang L, Ye H, Bajwa A, Chattrabhuti K, Lee S, et al. Ultrasound prevents renal ischemia-reperfusion injury by stimulating the splenic cholinergic anti-inflammatory pathway. J Am Soc Nephrol (2013) 24(9):1451-60. doi:10.1681/ASN.2013010084
172. Park P, Haas M, Cunningham PN, Bao L, Alexander JJ, Quigg RJ. Injury in renal ischemia-reperfusion is independent from immunoglobulins and T lymphocytes. Am J Physiol Renal Physiol (2002) 282(2):F352-7. doi:10.1152/ajprenal.00160.2001
173. Gorevic PD. Rheumatoid factor, complement, and mixed cryoglobulinemia. Clin Dev Immunol (2012) 2012:6. doi:10.1155/2012/439018
174. Charles ED, Dustin LB. Hepatitis C virus-induced cryoglobulinemia. Kidney Int (2009) 76(8):818-24. doi:10.1038/ki.2009.247
175. Kubagawa H, Oka S, Kubagawa Y, Torii I, Takayama E, Kang D, et al. Identity of the elusive IgM Fc receptor (FcμR) in humans. J Exp Med (2009) 206(12):2779-93. doi:10.1084/jem.20091107
176. Marchalonis JJ, Schluter SF, Wang E, Dehghanpisheh K, Lake D, Yocum DE, et al. Synthetic autoantigens of immunoglobulins and T-cell receptors: their recognition in aging, infection, and autoimmunity. Proc Soc Exp Biol Med (1994) 207(2):129-47. doi:10.3181/00379727-207-43801
177. Vassilev T, Mihaylova N, Voynova E, Nikolova M, Kazatchkine M, Kaveri S. IgM-enriched human intravenous immunoglobulin suppresses T lymphocyte functions in vitro and delays the activation of T lymphocytes in hu-SCID mice. Clin Exp Immunol (2006) 145(1):108-15. doi:10.1111/j.1365-2249.2006.03098.x
178. Kinsey GR, Sharma R, Huang L, Li L, Vergis AL, Ye H, et al. Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J Am Soc Nephrol (2009) 20(8):1744-53. doi:10.1681/ASN.2008111160
179. Kendall PL, Woodward EJ, Hulbert C, Thomas JW. Peritoneal B cells govern the outcome of diabetes in non-obese diabetic mice. Eur J Immunol (2004) 34(9):2387-95. doi:10.1002/eji.200324744
180. Ryan GA, Wang CJ, Chamberlain JL, Attridge K, Schmidt EM, Kenefeck R, et al. B1 cells promote pancreas infiltration by autoreactive T cells. J Immunol (2010) 185(5):2800-7. doi:10.4049/jimmunol.1000856
181. Xiu Y, Wong CP, Bouaziz JD, Hamaguchi Y, Wang Y, Pop SM, et al. B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions. J Immunol (2008) 180(5):2863-75. doi:10.4049/jimmunol.180.5.2863
182. Chhabra P, Schlegel K, Okusa MD, Lobo PI, Brayman KL. Naturally occurring immunoglobulin M (nIgM) autoantibodies prevent autoimmune diabetes and mitigate inflammation after transplantation. Ann Surg (2012) 256(4):634-41. doi:10.1097/SLA.0b013e31826b4ba9
183. Andersson Å, Forsgren S, Söderström Å, Holmberg D. Monoclonal, natural antibodies prevent development of diabetes in the non-obese diabetic (NOD) mouse. J Autoimmun (1991) 4(5):733-42. doi:10.1016/0896-8411(91)90169-D
184. Andersson A, Ekstrand-Hammarstrom B, Eriksson B, Overmo C, Holmberg D. Neonatal treatment with monoclonal natural antibodies restores a normal pattern of VH gene utilization in the non-obese diabetic mouse. Int Immunol (1994) 6(4):623-30. doi:10.1093/intimm/6.4.623
185. Symmons DP. Frequency of lupus in people of African origin. Lupus (1995) 4(3):176-8. doi:10.1177/096120339500400303
186. Lobo PI. The first reported case of sarcoidosis in an East African. East Afr Med J (1972) 49(1):37-49.
187. Jacyk WK. Sarcoidosis in the West African. A report of eight Nigerian patients with cutaneous lesions. Trop Geogr Med (1984) 36(3):231-6.
188. Lobo PI, Suratt PM. Studies on the autoantibody to lymphocytes in sarcoidosis. J Clin Lab Immunol (1979) 1(4):283-8.